Activation of human ovarian cancer cells: role of lipid factors in ascitic fluid
Normal cells proliferate in response to injury or to replace cells with a limited survival time. This is true for cells in the hematopoietic system and epithelial cells of the skin and bowel. It has been estimated that 1 million cell divisions per second are required for the replacement of lost cells. The proliferation of normal cells is regulated by the action of a number of polypeptide and lipid factors called growth factors [1–8]. These growth factors bind to specific cell surface receptors and transmit activation signals across the cell membrane. These signals initiate a limited number of intracellular biochemical cascades which in turn communicate with the nucleus, eventually leading to cellular proliferation [5–8]. In addition to positive growth signals, a series of proteins is involved in limiting cellular proliferation [9–10]. Several of these, such as p53 and the product of the retinoblastoma gene (RB), are more commonly known as tumor suppressor genes [9,10]. Finally, some activated cells are sensitized to a physiological process Known as programmed cell death or apoptosis [11–13]. Both the products of tumor suppressor genes and the products of the genes involved in programmed cell death must be overcome for a cell to divide.
KeywordsOvarian Cancer Ovarian Cancer Cell Ascitic Fluid Ovarian Cancer Patient Lipid Mediator
Unable to display preview. Download preview PDF.
- 8.Schmandt, R. and Mills, G.B. (1993) Genomic components of carcinogenesis. Clin, Chem., 39, 2375–85.Google Scholar
- 12.Grivell, L.A and Jacobs, H.T. (1992) Oncogenes, mitochondria and immortality. Curr. Opin. Immunol, 1,94–6.Google Scholar
- 14.Mills, G.B., Hashimoto, S., Hurteau, J. et al, (1992) Regulation of growth of human ovarian cancer cells. In Ovarian Cancer 2: Biology, Diagnosis and Management, (eds. F. Sharp Mason and W. Creaseman), Chapman & Hall, London, pp. 127–43.Google Scholar
- 17.Mills, G.B., Hashimoto, S., Hurteau, J.A. et al., (1992) Role of growth factors, their receptors, and signaling pathways in the diagnosis, prognosis, follow-up and therapy of ovarian cancer. Diagn. Oncol., 2,39–54.Google Scholar
- 19.Mills, G.B. and May C. (1989) Regulatory mechanisms in ascitic fluid. In Ovarian Cancer: Biologic and Therapeutic Challenges, (eds. F. Sharp, W.P. Mason and R.E. Leake), Chapman & Hall, London, pp. 55–62.Google Scholar
- Hurteau, J., Simon, H.U., Kurman, C. et al, (1993) Levels of the soluble interleukin 2 receptor alpha are elevated in epithelial ovarian cancer patients: evidence for activation of T lymphocytes and potential role in management of ovarian cancer. Am. J. Obstet. Gynecol., in press.Google Scholar
- 38.Kates, M. (1978) Techniques of Lipidology, 2nd edn. Elsevier, Amsterdam.Google Scholar